Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Current Medicinal Chemistry|April 8, 2003
Structure-activity relationship in cationic lipid mediated gene transfectionDan Niculescu-Duvaz, James Heyes, Caroline J SpringerBioconjugate Chemistry|April 3, 2008
Long functionalized poly(ethylene glycol)s of defined molecular weight: synthesis and application in solid-phase synthesis of conjugatesDan Niculescu-Duvaz, Jayne Getaz, Caroline J SpringerJournal of Medicinal Chemistry|January 5, 2002
Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transferJames A Heyes, Dan Niculescu-Duvaz, Robert G Cooper, et al.Expert Opinion on Therapeutic Patents|January 9, 2013
BRAF as a therapeutic target: a patent review (2006 - 2012)Alfonso Zambon, Dan Niculescu-Duvaz, Ion Niculescu-Duvaz, et al.Bioorganic & Medicinal Chemistry Letters|January 7, 2012
Small molecule inhibitors of BRAF in clinical trialsAlfonso Zambon, Ion Niculescu-Duvaz, Dan Niculescu-Duvaz, et al.Journal of Medicinal Chemistry|April 18, 2003
Self-immolative nitrogen mustards prodrugs cleavable by carboxypeptidase G2 (CPG2) showing large cytotoxicity differentials in GDEPTDan Niculescu-Duvaz, Ion Niculescu-Duvaz, Frank Friedlos, et al.Cancer Research|April 3, 2004
V599EB-RAF is an oncogene in melanocytesClaudia Wellbrock, Lesley Ogilvie, Douglas Hedley, et al.Cancer Cell|March 14, 2007
The EGF receptor Hokey-CokeyDan Niculescu-Duvaz, Steven Whittaker, Caroline Springer, et al.Oncogene|June 23, 2004
B-RAF is a therapeutic target in melanomaMaria Karasarides, Antonio Chiloeches, Robert Hayward, et al.Journal of Medicinal Chemistry|January 6, 2006
Novel inhibitors of B-RAF based on a disubstituted pyrazine scaffold. Generation of a nanomolar leadIon Niculescu-Duvaz, Esteban Roman, Steven R Whittaker, et al.Pageof 8